|
1
|
Shin DH, Sinn DH, Kim YH, Kim JY, Chang
DK, Kim EJ, Ryu HY, Song HU, Kim IY, Kim do H, et al: Increasing
incidence of inflammatory bowel disease among young men in Korea
between 2003 and 2008. Dig Dis Sci. 56:1154–1159. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cucchiara S and Stronati L: Incidence in
pediatric IBD is rising: Help from health administrative data.
Inflamm Bowel Dis. 17:1048–1049. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rufo PA and Bousvaros A: Challenges and
progress in pediatric inflammatory bowel disease. Curr Opin
Gastroenterol. 23:406–412. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hugot JP and Bellaiche M: Inflammatory
bowel diseases: The paediatric gastroenterologist's perspective.
Pediatr Radiol. 37:1065–1070. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yamamoto H, Sekine Y, Sato Y, Higashizawa
T, Miyata T, Iino S, Ido K and Sugano K: Total enteroscopy with a
nonsurgical steerable double-balloon method. Gastrointest Endosc.
53:216–220. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Di Nardo G, de Ridder L, Oliva S, Casciani
E, Escher JC and Cucchiara S: Enteroscopy in paediatric Crohn's
disease. Dig Liver Dis. 45:351–355. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Levine JS and Burakoff R: Extraintestinal
manifestations of inflammatory bowel disease. Gastroenterol Hepatol
(N Y). 7:235–241. 2011.PubMed/NCBI
|
|
8
|
Sands BE, Tremaine WJ, Sandborn WJ,
Rutgeerts PJ, Hanauer SB, Mayer L, Targan SR and Podolsky DK:
Infliximab in the treatment of severe, steroid-refractory
ulcerative colitis: A pilot study. Inflamm Bowel Dis. 7:83–88.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Danese S, Colombel JF, Reinisch W and
Rutgeerts P: Review article: Infliximab for Crohn's disease
treatment-shifting therapeutic strategies after 10 years of
clinical experience. Aliment Pharmacol Ther. 33:857–869. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Järnerot G, Hertervig E, Friis-Liby I,
Blomquist L, Karlén P, Grännö C, Vilien M, Ström M, Danielsson A,
Verbaan H, et al: Infliximab as rescue therapy in severe to
moderately severe ulcerative colitis: A randomized,
placebo-controlled study. Gastroenterology. 128:1805–1811. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dredge K, Marriott JB, Macdonald CD, Man
HW, Chen R, Muller GW, Stirling D and Dalgleish AG: Novel
thalidomide analogues display anti-angiogenic activity
independently of immunomodulatory effects. Br J Cancer.
87:1166–1172. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lentzsch S, LeBlanc R, Podar K, Davies F,
Lin B, Hideshima T, Catley L, Stirling DI and Anderson KC:
Immunomodulatory analogs of thalidomide inhibit growth of Hs Sultan
cells and angiogenesis in vivo. Leukemia. 17:41–44. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zheng CF, Xu JH, Huang Y and Leung YK:
Treatment of pediatric refractory Crohn's disease with thalidomide.
World J Gastroenterol. 17:1286–1291. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang XQ, Zhang Y, Xu CD, Jiang LR, Huang
Y, Du HM and Wang XJ: Inflammatory bowel disease in Chinese
children: A multicenter analysis over a decade from Shanghai.
Inflamm Bowel Dis. 19:423–428. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Society of Pediatrics of China,
Digestology group, . Consensus on diagnostic criteria of pediatric
inflammatory bowel disease. Chinese J Practical Pediatr.
25:263–265. 2010.(In Chinese).
|
|
16
|
Hyams JS, Ferry GD, Mandel FS, Gryboski
JD, Kibort PM, Kirschner BS, Griffiths AM, Katz AJ, Grand RJ, Boyle
JT, et al: Development and validation of a pediatric Crohns disease
activity index. J Pediatr Gastroenterol Nutr. 12:439–447. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Vermeire S, Van Assche G and Rutgeerts P:
Laboratory markers in IBD: Useful, magic, or unnecessary toys? Gut.
55:426–431. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pozler O, Maly J, Bonova O, Dedek P,
Frühauf P, Havlickova A, Janatova T, Jimramovsky F, Klimova L,
Klusacek D, et al: Incidence of Crohn disease in the Czech Republic
in the years 1990 to 2001 and assessment of pediatric population
with inflammatory bowel disease. J Pediatr Gastroenterol Nutr.
42:186–189. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Heyman MB, Kirschner BS, Gold BD, Ferry G,
Baldassano R, Cohen SA, Winter HS, Fain P, King C, Smith T and
El-Serag HB: Children with early-onset inflammatory bowel disease
(IBD): Analysis of a pediatric IBD consortium registry. J Pediatr.
146:35–40. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Prideaux L, Kamm MA, De Cruz PP, Chan FK
and Ng SC: Inflammatory bowel disease in Asia: A systematic review.
J Gastroenterol Hepatol. 27:1266–1280. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Auvin S, Molinié F, Gower-Rousseau C,
Brazier F, Merle V, Grandbastien B, Marti R, Lerebours E, Dupas JL,
Colombel JF, et al: Incidence, clinical presentation and location
at diagnosis of pediatric inflammatory bowel disease: A prospective
population-based study in northern France (1988–1999). J Pediatr
Gastroenterol Nutr. 41:49–55. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
IBD Working Group of the European Society
for Paediatric Gastroenterology, Hepatology and Nutrition, .
Inflammatory bowel disease in children and adolescents:
Recommendations for diagnosis-the Porto criteria. J Pediatr
Gastroenterol Nutr. 41:1–7. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mutalib M, Blackstock S, Evans V, Huggett
B, Chadokufa S, Kiparissi F and Elawad M: Eosinophilic
gastrointestinal disease and inflammatory bowel disease in
children: Is it a disease continuum? Eur J Gastroenterol Hepatol.
27:20–23. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dodell GB, Albu JB, Attia L, McGinty J,
Pi-Sunyer FX and Laferrère B: The bariatric surgery patient: Lost
to follow-up; From morbid obesity to severe malnutrition. Endocr
Pract. 18:e21–e25. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yüksel I, Ataseven H, Başar O, Köklü S,
Ertuğrul I, Ulker A, Dağlı U and Saşmaz N: Peripheral arthritis in
the course of inflammatory bowel diseases. Dig Dis Sci. 56:183–187.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cai C, Shen J, Zhao D, Qiao Y, Xu A, Jin
S, Ran Z and Zheng Q: Serological investigation of food specific
immunoglobulin G antibodies in patients with inflammatory bowel
diseases. PLoS One. 9:e1121542014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu S, Ren J, Xia Q, Wu X, Han G, Ren H,
Yan D, Wang G, Gu G and Li J: Preliminary case-control study to
evaluate diagnostic values of C-reactive protein and erythrocyte
sedimentation rate in differentiating active Crohn's disease from
intestinal lymphoma, intestinal tuberculosis and Behcet's syndrome.
Am J Med Sci. 346:467–472. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Castellaneta SP, Afzal NA, Greenberg M,
Deere H, Davies S, Murch SH, Walker-Smith JA, Thomson M and
Srivistrava A: Diagnostic role of upper gastrointestinal endoscopy
in pediatric inflammatory bowel disease. J Pediatr Gastroenterol
Nutr. 39:257–261. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mamula P, Telega GW, Markowitz JE, Brown
KA, Russo PA, Piccoli DA and Baldassano RN: Inflammatory bowel
disease in children 5 years of age and younger. Am J Gastroenterol.
97:2005–2010. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lin TK and Erdman SH: Double-balloon
enteroscopy: Pediatric experience. J Pediatr Gastroenterol Nutr.
51:429–432. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mensink PB, Groenen MJ, Van Buuren HR,
Kuipers EJ and Van der Woude CJ: Double-balloon enteroscopy in
Crohn's disease patients suspected of small bowel activity:
Findings and clinical impact. J Gastroenterol. 44:271–276. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Huang Y, Shao CH and Leung YK: Application
of double balloon enteroscopy in pediatric patients. Zhonghua Er Ke
Za Zhi. 48:599–602. 2010.(In Chinese). PubMed/NCBI
|
|
33
|
Robert ME, Tang L, Hao LM and Reyes-Mugica
M: Patterns of inflammation in mucosal biopsies of ulcerative
colitis: Perceived differences in pediatric populations are limited
to children younger than 10 years. Am J Surg Pathol. 28:183–189.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Washington K, Greenson JK, Montgomery E,
Shyr Y, Crissinger KD, Polk DB, Barnard J and Lauwers GY:
Histopathology of ulcerative colitis in initial rectal biopsy in
children. Am J Surg Pathol. 26:1441–1449. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pierik M, De Hertogh G, Vermeire S, Van
Assche G, Van Eyken P, Joossens S, Claessens G, Vlietinck R,
Rutgeerts P and Geboes K: Epithelioid granulomas, pattern
recognition receptors, and phenotypes of Crohn's disease. Gut.
54:223–227. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tiemi J, Komati S and Sdepanian VL:
Effectiveness of infliximab in Brazilian children and adolescents
with Crohn disease and ulcerative colitis according to clinical
manifestations, activity indices of inflammatory bowel disease, and
corticosteroid use. J Pediatr Gastroenterol Nutr. 50:628–633. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hyams JS, Lerer T, Griffiths A,
Pfefferkorn M, Stephens M, Evans J, Otley A, Carvalho R, Mack D,
Bousvaros A, et al: Pediatric Inflammatory Bowel Disease
Collaborative Research Group: Outcome following infliximab therapy
in children with ulcerative colitis. Am J Gastroenterol.
105:1430–1436. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Oldenburg B and Hommes D: Biological
therapies in inflammatory bowel disease: Top-down or bottom-up?
Curr Opin Gastroenterol. 23:395–399. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Facchini S, Candusso M, Martelossi S,
Liubich M, Panfili E and Ventura A: Efficacy of long-term treatment
with thalidomide in children and young adults with Crohn disease:
Preliminary results. J Pediatr Gastroenterol Nutr. 32:178–181.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lazzerini M, Martelossi S, Marchetti F,
Scabar A, Bradaschia F, Ronfani L and Ventura A: Efficacy and
safety of thalidomide in children and young adults with intractable
inflammatory bowel disease: Long-term results. Aliment Pharmacol
Ther. 25:419–427. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Stefan DC, Andronikou S, Freeman N and
Schoeman J: Recovery of vision after adjuvant thalidomide in a
child with tuberculous meningitis and acute lymphoblastic leukemia.
J Child Neurol. 24:166–169. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Schoeman JF, Fieggen G, Seller N,
Mendelson M and Hartzenberg B: Intractable intracranial tuberculous
infection responsive to thalidomide: Report of four cases. J Child
Neurol. 21:301–308. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Priolo T, Lamba LD, Giribaldi G, De Negri
E, Grosso P, De Grandis E, Veneselli E, Buoncompagni A, Viola S,
Alpigiani MG, et al: Childhood thalidomide neuropathy: A clinical
and neurophysiologic study. Pediatr Neurol. 38:196–199. 2008.
View Article : Google Scholar : PubMed/NCBI
|
